Atlas Trials

Fexofenadine Use in Gastroesophageal Reflux Symptoms

Clinical trial NCT03425097 · TERMINATED

Trial details

NCT number
NCT03425097
Sponsor
Stanford University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2018-02-07
Primary completion
2019-01-08
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.